Dr. Banjarapharmaceuticals Private Limited
About Dr. Banjarapharmaceuticals Private Limited
Data last updated:
Dr. Banjarapharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the animal health services segment of the veterinary services sector. It was incorporated on 20 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U85200HR2017PTC067163. Its GSTIN is 06AAFCD9794A2ZI (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rahul and Ravi Singh Banjara.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at H.No. – 132 Sec – 36 Mohammad Pur Jharsa, Gurgaon, Haryana, India – 122004.
As per the financials filed for FY 2020, the company reported a revenue of ₹5.1 Lakh. For the same year it recorded a net loss of ₹83,521 (net margin -16.4%) and EBITDA of -₹83,521 (EBITDA margin -16.4%).
Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dr. Banjarapharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. – 132 Sec – 36 Mohammad Pur Jharsa, Gurgaon, Haryana, India – 122004
- IndustryVeterinary, Animal Health Services
To see the full contact details of Dr. Banjarapharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr. Banjarapharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Dr. Banjarapharmaceuticals Private Limited, buy the company report.
Financials of Dr. Banjarapharmaceuticals Private Limited
FY 2020 filings availableDr. Banjarapharmaceuticals Private Limited reported revenue of ₹5.1 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹5.1 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹83,521 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹83,521 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -16.4% | |||
| Net Profit Margin | -16.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dr. Banjarapharmaceuticals Private Limited, buy the company report.
Board of directors of Dr. Banjarapharmaceuticals Private Limited
Dr. Banjarapharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Also directs: Brightworld Path Lab Private Limited | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
| Pooja | Additional Director | 08 Jul 2020 | 6 Years 3 Months | Current |
| Rekha Ben Banjara | Additional Director | 25 Apr 2020 | 6 Years 6 Months | Current |
| Ravi Singh Banjara | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Dr. Banjarapharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Take Care Nursing Private Limited | ₹5.15 Lakh (FY 2021) | Ghaziabad, Uttar Pradesh, India | ||||
| Mennonite Brethern Property Association of India Private Limited | ₹5.13 Lakh (FY 2023) | 0.0% | Chennai, Tamil Nadu, India | |||
| Kamakshiammal Diagnostics Private Limited | ₹5.13 Lakh (FY 2023) | -87.0% | Tiruchirappalli, Tamil Nadu, India | |||
| Insta Path Labs Private Limited | ₹5.13 Lakh (FY 2021) | -73.0% | Chandigarh, India | |||
| Aiocare Private Limited | ₹5.11 Lakh (FY 2023) | -50.0% | Bengaluru, Karnataka, India | |||
| Dr. Banjarapharmaceuticals Private Limitedthis company | ₹5.1 Lakh (FY 2020) | -₹83,521 | -16.4% | Gurgaon, Haryana, India | ||
| Smartsquad Healthcare (OPC) Private Limited | ₹5.1 Lakh (FY 2025) | 122.0% | Pune, Maharashtra, India | |||
| Bhuvanpati Vinayaka Nursing and Medical Research Private Limited | ₹5.1 Lakh (FY 2023) | Patna, Bihar, India | ||||
| Arogyashastra Private Limited | ₹5.09 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Barasat City Life Diagnostic Centre Private Limited | ₹5.09 Lakh (FY 2018) | -84.0% | Kolkata, West Bengal, India | |||
| Tervigon Collective Private Limited | ₹5.09 Lakh (FY 2025) | -69.0% | New Delhi, Delhi, India |
To see the full peer comparison of Dr. Banjarapharmaceuticals Private Limited, buy the company report.
Legal cases
Dr. Banjarapharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Civil miscellaneous application | Filed against the company by an individual | Disposed |
| District court, Gurugram, Haryana | Civil suit | Filed against the company by M/S Friend Medical Agency | Disposed |
| District court, Gurugram, Haryana | Court case (APP) | Filed against the company by an individual | Disposed |
To see the full case history of Dr. Banjarapharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr. Banjarapharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dr. Banjarapharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCD9794A2ZI | Haryana | Active | 29 Jul 2017 |
To see the full GST registrations and return filing status of Dr. Banjarapharmaceuticals Private Limited, buy the company report.
Recent activity
Dr. Banjarapharmaceuticals Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Pooja was appointed as Additional Director on 08 Jul 2020.
Frequently asked questions
Dr. Banjarapharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in animal health services, within the veterinary industry. It was incorporated on 20 January 2017 (9+ years old) and is registered under CIN U85200HR2017PTC067163.
Dr. Banjarapharmaceuticals has 4 current directors:
- Rahul - Director
- Pooja - Additional Director
- Rekha Ben Banjara - Additional Director
- Ravi Singh Banjara - Director
The latest financial statements of Dr. Banjarapharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Dr. Banjarapharmaceuticals is 06AAFCD9794A2ZI, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Dr. Banjarapharmaceuticals is U85200HR2017PTC067163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Banjarapharmaceuticals has 3 court cases on record: 3 filed against it.
Dr. Banjarapharmaceuticals was incorporated on 20 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Dr. Banjarapharmaceuticals by revenue are Take Care Nursing Private Limited, Mennonite Brethern Property Association of India Private Limited, Kamakshiammal Diagnostics Private Limited, Insta Path Labs Private Limited, Aiocare Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Pooja was appointed as Additional Director on 08 Jul 2020. Rekha Ben Banjara was appointed as Additional Director on 25 Apr 2020. Rahul was appointed as Director on 20 Jan 2017. Dr. Banjarapharmaceuticals has 4 board changes on record in total.
The registered office of Dr. Banjarapharmaceuticals is at H.No. – 132 Sec – 36 Mohammad Pur Jharsa, Gurgaon, Haryana, India – 122004.
Dr. Banjarapharmaceuticals operates in the veterinary industry, in the animal health services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
